Hypoglycemia in type 1 and type 2 diabetes: Physiology, pathophysiology, and management

Clinical Diabetes

Volumn 24, Issue 3, 2006, Pages 115-121

  Briscoe, Vanessa J ^a   Davis, Stephen N ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CARBOHYDRATE; GLUCOSE; INSULIN; MEGLITINIDE;

CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; EXERCISE; GLYCEMIC CONTROL; HORMONE RESPONSE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; REVIEW; RISK FACTOR;

EID: 33748366186     PISSN: 08918929     EISSN: 08918929     Source Type: Journal    
DOI: 10.2337/diaclin.24.3.115     Document Type: Review

References (48)

1. The DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long term complication in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
2. The U.K. Prospective Diabetes Study Group: Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes. Lancet 352:837-853, 1998
3. Cryer PE: Hypoglycemia risk reduction in type 1 diabetes. Exp Clin Endocrinol Diabetes 109:S412-S423, 2001
4. Cryer PE: Current concepts: Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 350:2272-2279, 2004
5. Cryer PE, Davis SN, Shamoon H: Hypoglycemia in diabetes. Diabetes Care 26:1902-1912, 2003
6. Cryer PE: Hypoglycemia: Pathophysiology, Diagnosis, and Treatment. New York, Oxford University Press, 1997
7. Diedrich L, Sandoval D, Davis SN: Hypoglycemia associated autonomic failure. Clin Auton Res 12:358-365, 2002
8. Zammitt NN, Frier BM: Hypoglycemia in type 2 diabetes. Diabetes Care 28:2948-2961, 2005
9. McAuley V, Deary IJ, Freier BM: Symptoms of hypoglycemia in people with diabetes. Diabet Med 18:690-705, 2001
10. Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV: Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 37:901-907, 1988
11. The DCCT Research Group: Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 46:271-286, 1997
12. Hepburn DA, MacLeod KM, Pell AC, Scougal IJ, Frier BM: Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin. Diabet Med 10:231-237, 1993
13. Donnelly LA, Morris AD, Frier BM, Ellis JD, Donnan PT, Durrant R, Band MM, Reekie G, Leese P: Frequency and predictors of hypoglycaemia in type 1 and insulin-treated type 2 diabetes: a population-based study. Diabet Med 22:749-755, 2005
14. Aftab-Guy D, Sandoval D, Richardson MA, Tate D, Davis SN: Effects of glycemic control on target organ responses to epinephrine in type 1 diabetes. Am J Physiol Endocrinol Metab 289:E258-E265, 2005
15. Korzon-Burakowska A, Hopkins D, Matyka K, Lomas J, Pernet A, Macdonald I, Amiel S: Effects of glycemic control on protective responses against hypoglycemia in type 2 diabetes. Diabetes Care 21:283-290, 1998
16. Boyle PJ, Schwartz NS, Shah SD, Clutter WE, Cryer PE: Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics. N Engl J Med 318:1487-1492, 1988
17. Heller SR, Cryer PE: Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes 4:223-226, 1991
18. Davis SN, Tate D: Effects of morning hypoglycemia on neuroendocrine and metabolic responses to subsequent afternoon hypoglycemia in normal man. J Clin Endocrinol Metab 86:2043-2050, 2001
19. Dagogo-Jack SE, Craft S, Cryer PE: Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. J Clin Invest 91:819-828, 1993
20. Segel SA, Paramore DS, Cryer PE: Defective glucose counterregulation in type 2 diabetes (Abstract). Diabetes 49: A131, 2000
21. Spyer G, Hattersley AT, MacDonald IA, Amiel S, MacLeod KM: Hypoglycaemic counterregulation at normal blood glucose concentrations in patients with well controlled type 2 diabetes. Lancet 356:1970-1974, 2000
22. Meneilly GS, Cheung E, Tuokko H: Altered responses to hypoglycemia of healthy elderly people. Diabetes 43:403-410, 1994
23. Jaap AJ, Jones GC, McCrimmon RJ, Deary IJ, Frier BM: Perceived symptoms of hypoglycaemia in elderly type 2 diabetic patients treated with insulin. Diabet Med 15:398-401, 1998
24. Shorr RI, Ray WA, Daugherty JR, Griffin MR: Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med 157:1681-1686, 1997
25. Matyka K, Evans M, Lomas J, Cranston I, MacDonald I, Amiel SA: Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care 20:135-141, 1997
26. Amiel SA, Maran A, Powrie JK, Umpleby AM, MacDonald IA: Gender differences in counterregulation to hypoglycemia. Diabetologia 36:460-464, 1993
27. Davis SN, Goldstein RE, Price L, Jacobs J, Cherringon AD: The effects of insulin on the counterregulatory response to equivalent hypoglycemia in patients with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 77:1300-1307, 1993
28. Diamond MP, Jones T, Caprio S, Hallarman L, Diamond MC, Addabbo M, Tamborlane WV, Sherwin RS: Gender influences counterregulatory hormone responses to hypoglycemia. Metabolism 42:1568-1572, 1993
29. Davis SN, Fowler S, Costa F: Hypoglycemic counterregulatory responses differ between men and women with type 1 diabetes. Diabetes 49:65-72, 2000
30. Sandoval DA, Ertl AC, Richardson MA, Tate DB, Davis SN: Estrogen blunts neuroendocrine and metabolic responses to hypoglycemia. Diabetes 52:1749-1755, 2003
31. Cryer PE: Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes 54:3592-3598, 2005
32. White NH, Skor A, Cryer PE, Levandoski L, Dier DM, Santiago JV: Identification of type 1 diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med 308:485-491, 1993
33. Davis SN, Shavers C, Mosqueda-Garcia R, Costa F: Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans. Diabetes 46:1328-1335, 1997
34. Korytkowski MT, Mokan M, Veneman TE, Mitrakou A, Cryer PE, Gerich JE: Reduced beta-adrenergic sensitivity in patients with type 1 diabetes and hypoglycemia unawareness. Diabetes Care 21:1939-1943, 1998
35. Fritsche A, Stefan N, Haring H, Gerich J, Stumvoll M: Avoidance of hypoglycemia restores hypoglycemia awareness by increasing beta-adrenergic sensitivity in type 1 diabetes. Ann Intern Med 134:729-736, 2001
36. Cranston I, Lomas J, Maran A, Macdonald I, Amiel SA: Restoration of hypoglycemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 344:283-287, 1994
37. Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Ciofetta M, Modarelli F, DiVincenzo A, Annibale B, Lepore M, Lalli C, Sindaco P, Brunetti P, Bolli G: Relative roles of insulin and hypoglycemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycemia in male and female humans. Diabetologia 37:797-807, 1994
38. Dagogo-Jack S, Rattarasarn C, Cryer PE: Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 43:1426-1434, 1994
39. de Galan BE, Hoekstra JBL: Glucose counterregulation in type 2 diabetes mellitus. Diabet Med 18:519-527, 2001
40. Segel SA, Paramore DS, Cryer PE: Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes 51:724-732, 2002
41. The DCCT Research Group: Epidemiology of severe hypoglycemia in the diabetes control and complication trial. Am J Med 90:450-459, 1991
42. Gabriely I, Shamoon H: Hypoglycemia in diabetes: common, often unrecognized. Cleveland Clin J Med 71:335-342, 2004
43. Cryer PE, Childs BP: Negotiating the barrier of hypoglycemia in diabetes. Diabetes Spectrum 15:20-27, 2002
44. Heller SR, Amiel SA, Mansell P: Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. Diabetes Care 22:1607-1611, 1999
45. Ratner RE, Hirsch IB, Neifing JL, Garg SK, Mecca TE,Wilson CA: Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. Diabetes Care 23:639-643, 2000
46. Muhlhause I, Overmann H, Bender R, Bott U, Berger M: Risk factors of severe hypoglycemia in adult patients with type 1 diabetes - a prospective population based study. Diabetologia 41:1274-1282, 1998
47. Perriello G, DeFeo P, Torlone E, Fanelli C, Santeusanio F, Brunetti P, Bolli GB: The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity. Diabetologia 34:21-28, 1991
48. Wright EE: Treat to target: ABCs for the elderly. DOC News 3:4, 2006